Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward J Stepanski

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Journal of Pain and Symptom Management|January 28, 2003
Sleep and quality of life in breast cancer patientsBarry V Fortner, Edward J Stepanski, Stephanie C Wang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2009
Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancerLee S Schwartzberg, Patrick Cobb, Mark S Walker, et al.
Psychosomatic Medicine|June 9, 2007
Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressureRachel D Wells, Kenneth E Freedland, Robert M Carney, et al.
Gynecologic Oncology|September 11, 2012
Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinomaTodd D Tillmanns, M Patrick Lowe, Mark S Walker, et al.
Health and Quality of Life Outcomes|June 22, 2011
Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patientsMark S Walker, Murad Hasan, Yeun Mi Yim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2008
Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice: results of a multicenter studyLee S Schwartzberg, Edward J Stepanski, Mark S Walker, et al.
Journal of Medical Economics|August 8, 2013
Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancerPaul J E Miller, Sanjeev Balu, Deborah Buchner, et al.
Clinical Lung Cancer|November 11, 2009
Second- and third-line treatment of patients with non-small-cell lung cancer with erlotinib in the community setting: retrospective study of patient healthcare utilization and symptom burdenEdward J Stepanski, Arthur C Houts, Lee S Schwartzberg, et al.
Therapeutic Advances in Hematology|April 5, 2013
Symptom Burden and Quality of Life in Patients with Follicular Lymphoma undergoing Maintenance Treatment with Rituximab Compared with ObservationMark S Walker, Edward J Stepanski, Carolina Reyes, et al.
BMC Research Notes|June 22, 2012
Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancerMark S Walker, Elaine Yu Pharm, Jiandong Kerr, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Journal of Pain and Symptom Management|January 28, 2003
Sleep and quality of life in breast cancer patientsBarry V Fortner, Edward J Stepanski, Stephanie C Wang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2009
Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancerLee S Schwartzberg, Patrick Cobb, Mark S Walker, et al.
Psychosomatic Medicine|June 9, 2007
Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressureRachel D Wells, Kenneth E Freedland, Robert M Carney, et al.
Gynecologic Oncology|September 11, 2012
Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinomaTodd D Tillmanns, M Patrick Lowe, Mark S Walker, et al.
Health and Quality of Life Outcomes|June 22, 2011
Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patientsMark S Walker, Murad Hasan, Yeun Mi Yim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2008
Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice: results of a multicenter studyLee S Schwartzberg, Edward J Stepanski, Mark S Walker, et al.
Journal of Medical Economics|August 8, 2013
Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancerPaul J E Miller, Sanjeev Balu, Deborah Buchner, et al.
Clinical Lung Cancer|November 11, 2009
Second- and third-line treatment of patients with non-small-cell lung cancer with erlotinib in the community setting: retrospective study of patient healthcare utilization and symptom burdenEdward J Stepanski, Arthur C Houts, Lee S Schwartzberg, et al.
Therapeutic Advances in Hematology|April 5, 2013
Symptom Burden and Quality of Life in Patients with Follicular Lymphoma undergoing Maintenance Treatment with Rituximab Compared with ObservationMark S Walker, Edward J Stepanski, Carolina Reyes, et al.
BMC Research Notes|June 22, 2012
Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancerMark S Walker, Elaine Yu Pharm, Jiandong Kerr, et al.
Pageof 5